Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Skin reactions from cancer treatments might predict how well the treatments work.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

Tadalafil and Finasteride may help treat aggressive melanoma.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.